Biopharmaceutical Giant Amgen Places Its $200 Million Media Account in Review

MEC and SSCG are incumbents

Amgen, the world’s largest independent biotechnology firm, has launched its first full media review in more than 14 years.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in